Brief: scPharmaceuticals Q3 Revenue USD 3.796 Million Vs. IBES Estimate USD 3.39 Million
Nov 08 (Reuters) - scPharmaceuticals Q3 basic EPS USD -0.41. * Q3 operating expenses USD 18.635 million * Q3 income from operations USD -14.839 million * Q3 net income USD -15.634 million